The objective of the TRIUMPH study (Preventive Treatment of Migraine: Outcomes for Patients in Real-World Healthcare Systems) is to evaluate the real-world effectiveness of Emgality, in comparison to other preventive treatments for migraine, among people receiving routine medical care who are switching or beginning a new prescription treatment for migraine prevention.
Sponsor(s)
Eli Lilly and Company
Principal Investigator(s)
Dr. Perry Richardson
Contact Phone Number
Request Information